LOS ANGELES--(BUSINESS WIRE)--Nov. 8, 2005--Clearant, Inc. (OTCBB: CLRI), the developer of the patent-protected CLEARANT PROCESS(R) for pathogen inactivation, today announced that it has signed...
LOS ANGELES--(BUSINESS WIRE)--Oct. 21, 2005--Clearant, Inc. (OTCBB: CLRI), the developer of the patent-protected CLEARANT PROCESS(R) for pathogen inactivation, announced today that its Chief...
LOS ANGELES--(BUSINESS WIRE)--Sept. 27, 2005--Clearant, Inc. (OTCBB: CLRI), the developer of the patent-protected CLEARANT PROCESS(R) for pathogen inactivation, announced today that Bone Bank...
LOS ANGELES--(BUSINESS WIRE)--Sept. 21, 2005--Clearant, Inc. (OTCBB: CLRI), the developer of the patent-protected CLEARANT PROCESS(R) for pathogen inactivation, announced today that it presented...
LOS ANGELES--(BUSINESS WIRE)--Sept. 20, 2005-- Findings Demonstrate that "High Doses of Gamma Irradiation are Both Necessary and Feasible When Sterilizing Allograft Tissues with Gamma...
#3: CLRI News Clearant Launches New Sterilization Service; Tissue Banks Will Now Be Able to Comply with the FDA's New Good Tissue Practices on an Accelerated Basis
LOS ANGELES--(BUSINESS WIRE)--Sept. 19, 2005--Clearant, Inc. (OTCBB: CLRI), the developer of the patent protected CLEARANT PROCESS(R) for pathogen inactivation, announced today that it has launched...
LOS ANGELES--(BUSINESS WIRE)--Aug. 19, 2005--Clearant, Inc. (OTCBB: CLRI), the developer of the patent protected CLEARANT PROCESS(R) for pathogen inactivation, commented today on the recent...
